Phenelzine

Primary Uses

Phenelzine is primarily prescribed to treat depression. It belongs to a class of drugs known as monoamine oxidase inhibitors (MAOIs). Because of its potential for serious side effects and strict dietary requirements, it is typically reserved for patients who have not found relief from other antidepressant medications.

Specific Types of Depression

This medication is often used for patients with clinical features characterized as atypical, nonendogenous, or neurotic depression. It may be particularly helpful for the following situations:

• Atypical Depression: This type of depression often involves mood reactivity, meaning the person's mood improves in response to positive events. It may also include symptoms like increased appetite, sleeping too much, or a heavy feeling in the arms and legs.
• Treatment-Resistant Depression: Phenelzine is frequently used when other classes of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants, have failed to work.
• Depression with Anxiety: It is sometimes used when depression is accompanied by significant symptoms of anxiety or phobias.

Mechanism of Action

Phenelzine works by inhibiting the activity of monoamine oxidase, a natural enzyme in the body. This enzyme is responsible for breaking down neurotransmitters, which are chemical messengers that transmit signals between nerve cells in the brain.

By blocking this enzyme, phenelzine increases the concentration of several key neurotransmitters, including:

• Serotonin: Often associated with mood regulation and feelings of well-being.
• Norepinephrine: Involved in alertness, energy, and the stress response.
• Dopamine: Linked to pleasure, motivation, and motor function.

Higher levels of these chemicals can improve brain cell communication and help stabilize mood. Because it targets these pathways differently than more modern antidepressants, phenelzine is often used for individuals whose symptoms have not improved with other treatments.

Common Side Effects

Phenelzine may cause side effects as your body adjusts to the medication. Common side effects include:

• Dizziness, lightheadedness, or fainting, especially when standing up
• Drowsiness or fatigue
• Dry mouth
• Constipation
• Weight gain
• Upset stomach
• Muscle twitching or shaking
• Blurred vision
• Changes in sexual ability or desire

Serious Side Effects

Seek medical help immediately if you experience symptoms of a severe reaction, such as:

• Severe headache
• Stiff or sore neck
• Nausea and vomiting
• Fast, pounding, or irregular heartbeat
• Chest pain
• Sweating and fever, sometimes with cold or clammy skin
• Sensitivity to light or enlarged pupils
• Yellowing of the skin or eyes
• Swelling of the legs or feet
• New or worsening mental or mood changes, such as agitation or confusion

Suicidal Thoughts and Behaviors

Antidepressants may increase the risk of suicidal thinking and behavior in children, adolescents, and young adults. Families and caregivers should monitor for worsening depression, irritability, or unusual changes in behavior, especially during the first few months of treatment or when the dose is changed.

Hypertensive Crisis

Phenelzine can cause a life-threatening increase in blood pressure, known as a hypertensive crisis, if it is taken with certain foods, drinks, or medications. This reaction is often triggered by tyramine, a substance found in aged cheeses, air-dried or cured meats, fermented products, and certain alcoholic beverages. Symptoms of a hypertensive crisis include:

• Severe headache
• Stiff or sore neck
• Nausea and vomiting
• Sweating and fever
• Fast or pounding heartbeat
• Sensitivity to light

Drug Interactions

Serious and sometimes fatal reactions can occur when phenelzine is combined with other medications. It should not be used with other antidepressants (such as SSRIs, SNRIs, or tricyclics), certain pain medications like meperidine, or many over-the-counter cold and allergy medicines. A waiting period of at least 14 days is typically required when switching between phenelzine and most other antidepressants to avoid dangerous interactions.

Serotonin Syndrome

There is a risk of serotonin syndrome, a potentially life-threatening condition, when phenelzine is used with other drugs that affect serotonin levels. Symptoms may include agitation, hallucinations, rapid heart rate, muscle stiffness, or tremors.

Medical History and Contraindications

Phenelzine is generally not recommended for individuals with certain health conditions, including:

• Pheochromocytoma (an adrenal gland tumor)
• Congestive heart failure or severe heart disease
• A history of stroke or liver disease
• Severe kidney impairment

General Precautions

This medication may cause dizziness or drowsiness, which can impair the ability to drive or operate machinery. It may also cause a sudden drop in blood pressure when standing up, known as orthostatic hypotension. Regular blood pressure monitoring is often recommended during treatment to ensure safety.

Pregnancy

There is limited research on the effects of phenelzine during human pregnancy. Animal studies have indicated potential risks, but well-controlled studies in humans are not available. As a monoamine oxidase inhibitor (MAOI), phenelzine can cause severe interactions with certain foods and medications, leading to dangerously high blood pressure that may pose risks to both the pregnant person and the fetus.

If you are pregnant or planning to become pregnant, it is important to discuss your treatment options with your healthcare provider. They will help determine if the benefits of the medication justify the potential risks to the pregnancy.

Breastfeeding

It is unknown whether phenelzine passes into breast milk or if it could harm a nursing infant. Because many medications are excreted in breast milk, caution is recommended. You should consult with a healthcare professional to discuss the safety of breastfeeding while taking phenelzine and to evaluate the potential risks to the infant.

Available Forms

Phenelzine is currently available in the following form:

• Oral Tablet: This medication is taken by mouth, typically several times per day as directed by a healthcare provider.

FDA Approval and Indications

Phenelzine was approved by the U.S. Food and Drug Administration (FDA) for the treatment of depression. It is specifically indicated for patients clinically characterized as having atypical, nonendogenous, or neurotic depression who have not responded to other antidepressant therapies.

Boxed Warning

The FDA requires a boxed warning for phenelzine, which is standard for all antidepressant medications. This warning indicates that antidepressants may increase the risk of suicidal thinking and behavior in children, adolescents, and young adults (ages 18 to 24) during the early stages of treatment. Phenelzine is not approved for use in pediatric patients.

Regulatory Classification

• Prescription Status: Phenelzine is a prescription-only medication.
• Controlled Substance: It is not a controlled substance.
• Safety Monitoring: While there is no specific Risk Evaluation and Mitigation Strategy (REMS) program, the FDA mandates that patients of all ages starting antidepressant therapy be monitored closely for clinical worsening, suicidality, or unusual changes in behavior.

Withdrawal Symptoms

Stopping phenelzine suddenly can lead to withdrawal symptoms, sometimes referred to as discontinuation syndrome. These effects may begin shortly after the medication is stopped or the dose is significantly reduced.

Reported withdrawal symptoms include:

• Nausea and vomiting
• Dizziness
• Agitation or irritability
• Sleep disturbances, such as insomnia or vivid nightmares
• Headache
• General feeling of being unwell (malaise)

In some instances, more severe reactions have been reported, including hallucinations, psychosis, and seizures. Because of these risks, it is essential to follow a medical professional's guidance when stopping this medication.

How to Stop Safely

To minimize the risk of withdrawal, healthcare providers typically recommend a gradual reduction of the dose over a period of time. Do not stop taking phenelzine or change your dosing schedule without consulting your doctor first.